MANH Form 4 — Richards Bruce Receives 974 RSUs; Ownership 25,602
Rhea-AI Filing Summary
Form 4 summary — Manhattan Associates, Inc. (MANH)
On 07/30/2025 Richards Bruce, reported as SVP, CLO & Secretary, was granted 974 restricted stock units (RSUs) under the issuer's stock incentive plan. The transaction is reported as an acquisition at a recorded price of $0.0000. Following the grant, the filing shows Bruce beneficially owns 25,602 shares of common stock. The RSUs vest 25% on January 31 of each year following the grant date until fully vested, per the explanation in the filing. The Form 4 was signed by attorney-in-fact David M. Eaton on 08/04/2025. Table II reports no derivative securities.
Positive
- Grant recorded: 974 restricted stock units granted on 07/30/2025
- Vesting schedule disclosed: 25% vesting on January 31 each year until fully vested
- Post-transaction ownership: Reporting person beneficially owns 25,602 shares following the grant
- Timely execution: Form signed by attorney-in-fact David M. Eaton on 08/04/2025
Negative
- None.
Insights
TL;DR: Senior officer received 974 RSUs on 07/30/2025; routine compensation disclosure with no derivatives reported.
The filing documents an equity grant to Richards Bruce, identified as SVP, CLO & Secretary, consisting of 974 restricted stock units recorded as an acquisition on 07/30/2025. The grant is described as subject to a standard multi-year vesting schedule of 25% on January 31 each year until fully vested. Following the grant Bruce's reported beneficial ownership is 25,602 shares. The Form 4 was executed by an attorney-in-fact on 08/04/2025. Based solely on the filing, this appears to be a routine equity compensation disclosure without reported derivative transactions.
TL;DR: Form 4 discloses an RSU grant to an officer with explicit vesting terms; disclosure appears compliant and procedural.
The document is a Section 16 Form 4 reporting an acquisition of 974 RSUs by Richards Bruce under the company stock incentive plan. The filing specifies a vesting cadence of 25% on January 31 of each year post-grant until full vesting and reports total beneficial ownership of 25,602 shares after the transaction. No derivative securities are listed in Table II. The Form bears a signature date of 08/04/2025 by an attorney-in-fact, consistent with required procedural disclosure for insider awards.
FAQ
What transaction did the MANH Form 4 report on 07/30/2025?
Who is the reporting person on the MANH Form 4?
How many shares does the reporting person own after the reported transaction?
What is the vesting schedule for the RSUs reported in the MANH Form 4?
Were any derivative securities reported in this Form 4 for MANH?
When was the Form 4 signed and by whom?